TuHURA Biosciences Inc. (HURA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    TuHURA Biosciences Inc.

    NASDAQ: HURA · Real-Time Price · USD
    2.37
    0.02 (0.85%)
    At close: Sep 10, 2025, 3:59 PM
    2.42
    2.11%
    After-hours: Sep 10, 2025, 07:27 PM EDT

    TuHURA Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 116.71K n/a n/a n/a
    Gross Profit
    		 -116.71K n/a n/a n/a
    Operating Income
    		 -17.65M -29.76M -9.93M -7.25M
    Interest Income
    		 361.63K 89.67K 57.35K n/a
    Pretax Income
    		 -21.68M -29.32M -9.37M -7.02M
    Net Income
    		 -21.68M -29.32M -9.37M -7.02M
    Selling & General & Admin
    		 4.2M 4.14M 2.01M 2.38M
    Research & Development
    		 13.34M 9.4M 7.93M 4.88M
    Other Expenses
    		 n/a 16.22M n/a n/a
    Operating Expenses
    		 17.53M 29.76M 9.93M 7.25M
    Interest Expense
    		 4.14M 18.69K n/a 629.29K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 -17.65M 29.76M 9.93M 7.25M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 186.63K 420.3K 46.28K 27.9K
    Shares Outstanding (Diluted)
    		 186.63K 420.3K 46.28K 27.9K
    EPS (Basic)
    		 -116.18 -69.75 -0.22 -251.47
    EPS (Diluted)
    		 -116.18 -69.75 -0.22 -251.47
    EBITDA
    		 -17.43M -29.12M -9.56M -6.01M
    EBIT
    		 -17.54M -29.3M -9.93M -6.39M
    Depreciation & Amortization
    		 116.71K 177.38K 373.09K 380.69K

    Add to Watchlist